VP
Verrica Pharmaceuticals Inc
🇺🇸XNAS.VRCAUnited StatesHealthcare
$4.61USDup +0.02 (+0.44%)OpenDelayed3:26 PM
Price$4.61+0.02 (+0.44%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92511W2070
- CUSIP
- 92511W108
Company
- Employees
- 76
- Headquarters
- West Chester, United States
- Website
- https://www.verrica.com
- CEO
- Dr. Jayson M. Rieger M.B.A., Ph.D.
Market
- Shares outstanding
- 17.2M
- Market cap
- $79.19M
Highlights
- Market cap
- $116.09M
- EPS LTM
- -$1.46
- P/E LTM
- -3.15calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $30.32M+106.21%up year on year
- Net income
- -$31.18M+35.84%up year on year
- Gross margin
- 85.89%-0.76%down year on year
- Free cash flow
- -$13.35M+71.82%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.